Q-PHARM DENIES TRIAL ALLEGATIONS

Q-PHARM DENIES TRIAL ALLEGATIONS

A HERSTON-BASED contract research company has denied an association with clinical trial consultancy Rewards for Research, following controversy surrounding alleged financial incentives for volunteers.

The Sunday Telegraph reported that Rewards for Research advertises on Facebook to attract young people as human guinea pigs, listing Q-Pharm as a client.

Under the National Health and Medical Research Council’s (NHMRC) ethical conduct rules, payments to volunteers should not be disproportionate to time involved or encourage participants to take risks.

It is alleged that the South Brisbane-based Rewards for Research had advertised for clinical trials worth up to $2000 for participants in some cases.

But Q-Pharm CEO Terry Hurst told brisbanebusinessnews.com.au that the consultancy was only a client for one trial between 2006 and 2007 and that his company had since severed ties with the organisation.

“They are not a client of ours and they’re not a company we’ve chosen to be associated with,” says Hurst.

“Volunteers, particularly in early phase trials, are reimbursed for their out-of-pocket expenses, as well as for their time and inconvenience. Reimbursements are generally less than the minimum wage.”

Hurst declined to comment on Q-Pharm’s current volunteer recruitment policies, but affirms they are ‘ethically approved’ and follow NHMRC guidelines.

Get our daily business news

Sign up to our free email news updates.

 
Whitefox Recruitment founder Luke Hemmings making strides as a careers leader
Partner Content
After relocating his Canberra-founded company Whitefox Recruitment to the Gold Coast la...
Whitefox Recruitment
Advertisement

Related Stories

ASIC secures its first court win for greenwashing against US giant Vanguard

ASIC secures its first court win for greenwashing against US giant Vanguard

The Australian corporate watchdog has caught out one of the world&r...

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Medicinal cannabis group Althea shaves $1.5m from its cost base through staff cutbacks

Australian-founded medicinal cannabis company Althea Group (ASX: AG...

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Charter Hall snares 15pc stake in Hotel Property Investments for $97m from 360 Capital

Listed funds manager 360 Capital Group (ASX: TGP) has offloaded its...

The party’s over: Splendour in the Grass festival cancelled for 2024

The party’s over: Splendour in the Grass festival cancelled for 2024

Splendour in the Grass, Australia’s largest winter music fest...